NASDAQ: SNSE
Sensei Biotherapeutics Inc Stock Ownership - Who owns Sensei Biotherapeutics?

Insider buying vs selling

Have Sensei Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Millennium Management LLC10% Owner2026-04-07300$32.25
$9.67kSell
Millennium Management LLC10% Owner2026-04-07205$29.72
$6.09kSell
Millennium Management LLC10% Owner2026-04-074,423$31.38
$138.81kSell
Millennium Management LLC10% Owner2026-04-071,108$33.38
$36.99kSell
Millennium Management LLC10% Owner2026-04-071,108$33.38
$36.99kBuy
Millennium Management LLC10% Owner2026-04-072,115$28.94
$61.21kSell
Millennium Management LLC10% Owner2026-04-061,214$31.02
$37.66kSell
Millennium Management LLC10% Owner2026-04-0645$31.96
$1.44kSell
Millennium Management LLC10% Owner2026-04-061,104$31.02
$34.25kBuy
Millennium Management LLC10% Owner2026-04-021,134$34.80
$39.46kSell

1 of 7

SNSE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SNSE insiders and whales buy or sell their stock.

SNSE Shareholders

What type of owners hold Sensei Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James Peyer398.19%5,343,479$93.94MInsider
Hs Investments I LP329.82%4,425,998$77.81MInsider
Vivo Capital LLC53.80%722,020$12.69MInstitution
Thomas G. Ricks51.09%685,632$12.05MInsider
Cormorant Asset Management LP22.82%306,222$5.38MInstitution
Cambrian Biopharma Inc11.56%155,142$2.73MInsider
Millennium Management LLC10.92%146,565$2.58MInstitution
Franklin Resources Inc9.95%133,506$2.35MInstitution
Stempoint Capital LP9.90%132,873$2.34MInstitution
Millennium Management LLC9.47%127,095$2.23MInsider

1 of 3

SNSE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNSE16.16%83.84%Net SellingNet Buying
MRKR2.76%97.24%
KTTA38.36%38.68%Net Buying
JSPR24.49%75.51%Net Buying
VYNE35.72%64.28%Net SellingNet Selling

Sensei Biotherapeutics Stock Ownership FAQ

Who owns Sensei Biotherapeutics?

Sensei Biotherapeutics (NASDAQ: SNSE) is owned by 160.70% institutional shareholders, 833.52% Sensei Biotherapeutics insiders, and 0.00% retail investors. James Peyer is the largest individual Sensei Biotherapeutics shareholder, owning 5.34M shares representing 398.19% of the company. James Peyer's Sensei Biotherapeutics shares are currently valued at $93.83M.

If you're new to stock investing, here's how to buy Sensei Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.